Baird’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$2.44M Buy
33,706
+8,848
+36% +$615K 0.03% 500
2014
Q4
$1.64M Sell
24,858
-6,127
-20% -$374K 0.02% 588
2014
Q3
$1.7M Buy
30,985
+385
+1% +$21.8K 0.02% 504
2014
Q2
$1.78M Sell
30,600
-949
-3% -$55.8K 0.02% 512
2014
Q1
$1.96M Buy
31,549
+247
+0.8% +$14.4K 0.03% 476
2013
Q4
$1.67M Buy
31,302
+792
+3% +$42.5K 0.03% 497
2013
Q3
$1.53M Sell
30,510
-356
-1% -$17.4K 0.03% 492
2013
Q2
$1.41M Buy
+30,866
New +$1.38M 0.03% 488

Other funds holding MD

Baird's MD Position: Q1 2015 in Review

Baird increased its Pediatrix Medical (MD) stake by 36% in Q1 2015, buying an estimated $615K and bringing the position to 33,706 shares worth $2.44M. The position accounts for 0.03% of the portfolio, ranked #500.

Baird first reported a position in MD in Q2 2013 and has held it in 8 quarters since. 353 funds tracked by Wall St. Rank hold MD as of Q1 2015.

  • Baird held 33,706 shares of Pediatrix Medical worth $2.44M as of Q1 2015.
  • Baird bought 8,848 Pediatrix Medical shares in Q1 2015, an estimated $615K.
  • Pediatrix Medical made up 0.03% of Baird's portfolio in Q1 2015, its #500 holding.
  • Baird first reported a position in Pediatrix Medical in Q2 2013 and has held it in 8 quarters since.
  • 353 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.